CHARLES RIVER LABORATORIES (CRL) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:CRL - US1598641074 - Common Stock
CRL Key Statistics, Chart & Performance
The current stock price of CRL is 203.16 USD. In the past month the price increased by 14.1%. In the past year, price increased by 9.13%.
CRL Latest News, Press Relases and Analysis
CRL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.85 | 217.58B | ||
| DHR | DANAHER CORP | 30.02 | 163.50B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 185.88 | 56.48B | ||
| A | AGILENT TECHNOLOGIES INC | 24.79 | 39.21B | ||
| IQV | IQVIA HOLDINGS INC | 19.43 | 38.49B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 33.87 | 28.95B | ||
| WAT | WATERS CORP | 30.3 | 22.91B | ||
| ILMN | ILLUMINA INC | 31.04 | 20.68B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 39.13 | 19.90B | ||
| MEDP | MEDPACE HOLDINGS INC | 39.99 | 16.11B | ||
| TEM | TEMPUS AI INC | N/A | 11.43B | ||
| RVTY | REVVITY INC | 20.2 | 10.97B |
Related stock screener links
About CRL
Company Profile
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. The company is headquartered in Wilmington, Massachusetts and currently employs 18,600 full-time employees. The company went IPO on 2000-06-23. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Company Info
CHARLES RIVER LABORATORIES
251 Ballardvale St
Wilmington MASSACHUSETTS 01887 US
CEO: James C. Foster
Employees: 19400
Phone: 17812226000
CHARLES RIVER LABORATORIES / CRL FAQ
What does CRL do?
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. The company is headquartered in Wilmington, Massachusetts and currently employs 18,600 full-time employees. The company went IPO on 2000-06-23. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Can you provide the latest stock price for CHARLES RIVER LABORATORIES?
The current stock price of CRL is 203.16 USD. The price increased by 0.14% in the last trading session.
Does CHARLES RIVER LABORATORIES pay dividends?
CRL does not pay a dividend.
What is the ChartMill rating of CHARLES RIVER LABORATORIES stock?
CRL has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the number of employees for CHARLES RIVER LABORATORIES?
CHARLES RIVER LABORATORIES (CRL) currently has 19400 employees.
Can you provide the market cap for CHARLES RIVER LABORATORIES?
CHARLES RIVER LABORATORIES (CRL) has a market capitalization of 10.00B USD. This makes CRL a Mid Cap stock.
CRL Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to CRL. When comparing the yearly performance of all stocks, CRL is one of the better performing stocks in the market, outperforming 85.56% of all stocks.
CRL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CRL. Both the profitability and the financial health of CRL get a neutral evaluation. Nothing too spectacular is happening here.
CRL Financial Highlights
Over the last trailing twelve months CRL reported a non-GAAP Earnings per Share(EPS) of 10.55. The EPS increased by 4.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.11% | ||
| ROE | -2.45% | ||
| Debt/Equity | 0.64 |
CRL Forecast & Estimates
For the next year, analysts expect an EPS growth of 0.16% and a revenue growth -0.56% for CRL